Phospholamban mutants compete with wild type for SERCA binding in living cells

► PLB phosphorylation in HEK cells increased FRET between YFP-PLB and CFP-SERCA. ► Competition: Expressing loss-of-function PLB mutants in the system decreased FRET. ► The FRET assay could screen potential therapeutic PLB mutants to activate SERCA.